As used in this part, unless the context otherwise requires:

(1) “Cancer” means and includes, but is not limited to:

Terms Used In Tennessee Code 68-1-1002

  • Cancer: means and includes, but is not limited to:
    (A) A large group of diseases characterized by uncontrolled growth and spread of abnormal cells. See Tennessee Code 68-1-1002
  • Commissioner: means the commissioner of health. See Tennessee Code 68-1-1002
  • Department: means the department of health. See Tennessee Code 68-1-1002
  • Facility: means a health care facility in which diagnosis or treatment services are provided to patients with cancer, including, but not limited to, an ambulatory surgical treatment center (ASTC), a freestanding cancer treatment center, a radiation therapy center, a chemotherapy treatment center, a nursing home, an oncology or dermatology clinic, a laboratory, or any other facility that provides screening, detection, diagnostic or therapeutic services to patients with cancer. See Tennessee Code 68-1-1002
  • Laboratory: means a facility where tests are performed identifying anatomical and cytological changes, and where specimens are interpreted and pathological diagnoses are made. See Tennessee Code 68-1-1002
(A) A large group of diseases characterized by uncontrolled growth and spread of abnormal cells;
(B) Any condition of tumors having the properties of anaplasia, invasion, and metastasis;
(C) A cellular tumor, the natural course of which is fatal;
(D) Malignant neoplasm; and
(E) In-situ cancer.
(2) “Commissioner” means the commissioner of health;
(3) “Department” means the department of health;
(4) “Facility” means a health care facility in which diagnosis or treatment services are provided to patients with cancer, including, but not limited to, an ambulatory surgical treatment center (ASTC), a freestanding cancer treatment center, a radiation therapy center, a chemotherapy treatment center, a nursing home, an oncology or dermatology clinic, a laboratory, or any other facility that provides screening, detection, diagnostic or therapeutic services to patients with cancer;
(5) “Health care practitioner” means a physician, surgeon, or other health care professional licensed under title 63 who is engaged in diagnosing and treating patients who have cancer;
(6) “Hospital” means an institution as defined by § 68-11-201;
(7) “In-situ cancer” means an abnormality of development and organization of cells. It is a condition of early cancer, without the invasion of neighboring tissue;
(8) “Laboratory” means a facility where tests are performed identifying anatomical and cytological changes, and where specimens are interpreted and pathological diagnoses are made; and
(9) “Medical, scientific and academic research communities” means those institutions that devote a substantial part of their activity to research and that have internal procedures providing for the collection, study and protection of data.